Rethinking molecular mimicry in rheumatic heart disease and autoimmune myocarditis: Laminin, collagen IV, CAR, and B1AR as initial targets of disease

Frontiers in Pediatrics

Volumn 2, Issue AUG, 2014, Pages

  Root Bernstein, Robert ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Antigenic complementarity; Co infection; Coxsackie virus; Epitope drift; Group A streptococci; Hidden antigens; Hyperinflammation; Theory

Indexed keywords

EID: 85041639068     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2014.00085     Document Type: Article

References (118)

1. Cunningham MW. Streptococcus and rheumatic fever. Curr Opin Rheumatol (2012) 24(4):408-16. doi:10.1097/BOR.0b013e32835461d3
2. Guilherme L, Kalil J. Rheumatic fever: from sore throat to autoimmune heart lesions. Int Arch Allergy Immunol (2004) 134(1):56-64. doi:10.1159/000077915
3. Ciháková D, Rose NR. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv Immunol (2008) 99:95-114. doi:10.1016/S0065-2776(08)00604-4
4. Rose NR, Hill SL. The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol (1996) 80(3 Pt 2):S92-9. doi:10.1006/clin.1996.0146
5. Henao-Martínez AF, Schwartz DA, Yang IV. Chagasic cardiomyopathy, from acute to chronic: is this mediated by host susceptibility factors? Trans R Soc Trop Med Hyg (2012) 106(9):521-7. doi:10.1016/j.trstmh.2012.06.006
6. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science (1999) 283:1335-9. doi:10.1126/science.283.5406.1335
7. Bachmaier K, Penninger JM. Chlamydia and antigenic mimicry. Curr Top Microbiol Immunol (2005) 296:153-63
8. Abrams D, Derrick G, Penny DJ, Shinebourne EA, Redington AN. Cardiac complications in children following infection with varicella zoster virus. Cardiol Young (2001) 11(6):647-52. doi:10.1017/S1047951101001019
9. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol (2003) 42:466-72. doi:10.1016/S0735-1097(03)00648-X
10. Sato Y, Yamada T, Matsumori A. Hepatitis C virus and cardiomyopathy. In: Matsumori A, editor. Cardiomyopathies and Heart Failure: Biomolecular, Infectious, and Immune Mechanisms. Boston, MA: Kluwer Academic Publishers (2003). p. 325-39
11. Andréoletti L, Lévêque N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Arch Cardiovasc Dis (2009) 102(6-7):559-68. doi:10.1016/j.aCXd.2009.04.010
12. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kuhl U, Schwimmbeck PL, et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation (1999) 99:1348-54. doi:10.1161/01.CIR.99.7.889
13. Panhoweit S, Lamparter S, Schoppet M, Maisch B. Parvovirus B19 genome in endomyocardial biopsy specimens. Circulation (2004) 109:e179. doi:10.1161/01.CIR.0000124881.00415.59
14. Mahfoud F, Gärtner B, Kindermann M, Ukena C, Gadomski K, Klingel K, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J (2011) 32(7):897-903. doi:10.1093/eurheartj/ehq493
15. Rose NR. The role of infection in the pathogenesis of autoimmune disease. Semin Immunol (1998) 10(1):5-13. doi:10.1006/smim.1997.0100
16. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis (2005) 5(11):685-94. doi:10.1016/S1473-3099(05)70267-X
17. Higgins PM. Splenomegaly in acute infections due to group A streptococci and viruses. Epidemiol Infect (1992) 109(2):199-209. doi:10.1017/S0950268800050160
18. Guilherme L, Köhler KF, Kalil J. Rheumatic heart disease: mediation by complex immune events. Adv Clin Chem (2011) 53:31-50. doi:10.1016/B978-0-12-385855-9.00002-3
19. Damian RT. A theory of immunoselection for eclipsed antigens of parasites and its implications for the problem of antigenic polymorphism in man. J Parasitol (1962) 48:16
20. Damian RT. Molecular mimicry: antigen sharing by parasite and host and its consequences. Am Nat (1964) 98:129-49. doi:10.1086/282313
21. Lane D, Koprowski H. Molecular recognition and the future of monoclonal antibodies. Nature (1982) 296(5854):200-2. doi:10.1038/296200a0
22. Fujinami RS, Oldstone MB, Wroblewska Z, Frankel ME, Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A (1983) 80(8):2346-50. doi:10.1073/pnas.80.8.2346
23. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science (1985) 230(4729):1043-5. doi:10.1126/science.2414848
24. Kaplan MH, Meyeserian M. An immunological cross-reaction between group A streptococcal cells and human heart tissue. Lancet (1962) 1:706. doi:10.1016/S0140-6736(62)91653-7
25. Kaplan MH. Immunologic relation of streptococcal and tissue antigens. I. Properties of an antigen in certain strains of group A streptococci exhibiting an immunologic cross-reaction with human heart tissue. J Immunol (1963) 90:595
26. Kaplan MH, Suchy ML. Immunologic relation of streptococcal and tissue antigens. II. Cross-reaction of antisera to mammalian heart tissue with a cell wall constituent of certain strains of group A streptococci. J Exp Med (1964) 119:643. doi:10.1084/jem.119.4.651
27. Kaplan MH. Rheumatic fever, rheumatic heart disease, and the streptococcal connection: the role of streptococcal antigens cross-reactive with heart tissue. Rev Infect Dis (1979) 1(6):988-986. doi:10.1093/clinids/1.6.988
28. Wood JN, Hudson L, Jessell TM, Yamamoto M. A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites. Nature (1982) 296:34-8. doi:10.1038/296034a0
29. Williams RC Jr. Rheumatic fever and the Streptococcus. Another look at molecular mimicry. Am J Med (1983) 75(5):727-30. doi:10.1016/0002-9343(83)90399-6
30. Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol (1989) 143(8):2677-83
31. Cunningham MW, McCormack JM, Talaber LR, Harley JB, Ayoub EM, Muneer RS, et al. Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart. J Immunol (1988) 141(8):2760-6
32. Myers JM, Fairweather D, Huber SA, Cunningham MW. Autoimmune myocarditis, valvulitis, and cardiomyopathy. Curr Protoc Immunol (2013) Chapter 15:Unit 15.14.1-51. doi:10.1002/0471142735.im1514s101
33. Davies AM. Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol (1997) 75:113-26. doi:10.1038/icb.1997.16
34. Rose NR, Mackay IR. Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci (2000) 57:542-51. doi:10.1007/PL00000716
35. Fourneau J-M, Bach J-M, van Endert PM, Bach J-F. The elusive case for a role of molecular mimicry in autoimmune diseases. Mol Immunol (2004) 40:1095-102. doi:10.1016/j.molimm.2003.11.011
36. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev (2006) 19(1):80. doi:10.1128/CMR.19.1.80-94.2006
37. Tandon R, Sharma M, Chandrasekhar Y, Kotb M, Yacoub MH, Narula J. Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol (2013) 10(3):171-7. doi:10.1038/nrcardio.2012.197
38. Gironès N, Cuervo H, Fresno M. Trypanosoma cruzi-induced molecular mimicry and Chagas; disease. Curr Top Microbiol Immunol (2005) 296:89-123
39. Rose NR. Autoimmunity in coxsackievirus infection. Curr Top Microbiol Immunol (2008) 323:293-314
40. Root-Bernstein RS, Vonck J, Podufaly A. Antigenic complementarity between coxsackie virus and streptococci in rheumatic heart disease and myocarditis. Autoimmunity (2009) 22(3):177-87. doi:10.1080/08916930802208540
41. Neu N, Ploier B, Ofner C. Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease. J Immunol (1990) 145(12):4094-100
42. Reddy J, Massilamany C, Buskiewicz I, Huber SA. Autoimmunity in viral myocarditis. Curr Opin Rheumatol (2013) 25(4):502-8. doi:10.1097/BOR.0b013e3283620036
43. De Scheerder IK, de Buyzere ML, Delanghe JR, Clement DL, Wieme RJ. Anti-myosin humoral immune response following cardiac injury. Autoimmunity (1989) 4(1-2):51-8. doi:10.3109/08916938909034359
44. De Scheerder IK, De Buyzere M, Delanghe J, Maas A, Clement DL, Wieme R. Humoral immune response against contractile proteins (actin and myosin) during cardiovascular disease. Eur Heart J (1991) 12:88-94. doi:10.1093/eurheartj/12.suppl_D.88
45. Morgun A, Shulzhenko N, Unterkircher CS, Diniz RV, Pereira AB, Silva MS, et al. Pre-and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome. J Heart Lung Transplant (2004) 23(2):204-9. doi:10.1016/S1053-2498(03)00114-1
46. Gupta M, Lent RW, Kaplan EL, Zabriskie JB. Serum cardiac troponin I in acute rheumatic fever. Am J Cardiol (2002) 89(6):779-82. doi:10.1016/S0002-9149(01)02358-X
47. Froude J, Gibofsky A, Buskirk DR, Khanna A, Zabriskie JB. Cross-reactivity between Streptococcus and human tissue: a model of molecular mimicry and autoimmunity. Curr Top Microbiol Immunol (1989) 145:5-26
48. Root-Bernstein RS. T cell receptor sequences from people with autoimmune diseases reveal potential infectious triggers and risks: a case study of type 1 diabetes mellitus and autoimmune myocarditis. J Theor Biol. (in press)
49. Srinivasappa J, Saegusa J, Prabhakar BS, Gentry MK, Buchmeier MJ, Wiktor TJ, et al. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol (1986) 57(1):397-401
50. Massilimany C, Gangaplara A, Steffen D, Reddy J. Identification of novel mimicry epitopes for cardiac myosin heavy chain-a that induce autoimmune myocarditis in A/J mice. Cell Immunol (2011) 271(2):438-49. doi:10.1016/j.cellimm.2011.08.013
51. Massilamany C, Huber SA, Cunningham MW, Reddy J. Relevance of molecular mimicry in the mediation of infectious myocarditis. J Cardiovasc Transl Res (2013) 7(2):165-71. doi:10.1007/s12265-013-9519-3
52. Root-Bernstein RS, Fairweather D. Complexities in the relationship between infection and autoimmunity. Curr Allergy Asthma Rep (2013) 14:407-14. doi:10.1007/s11882-013-0407-3
53. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol (1987) 139(11):3630-6
54. Wolfgram LJ, Beisel KW, Rose NR. Heart-specific autoantibodies following murine coxsackie B3 myocarditis. J Exp Med (1985) 161:1112-21. doi:10.1084/jem.161.5.1112
55. Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR. Variations in the susceptibility to coxsackie B3-induced myocarditis among different strains of mice. J Immunol (1986) 136:1846-53
56. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation (1999) 99:649-54. doi:10.1161/01.CIR.99.5.649
57. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S. Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2001) 37:418-24. doi:10.1016/S0735-1097(00)01109-8
58. Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, et al. Autoantibodies against the beta1-adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol (2001) 33:1515-25. doi:10.1006/jmcc.2001.1414
59. Freedman NJ, Lefkowitz RJ. Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation. J Clin Invest (2004) 113:1379-82. doi:10.1172/JCI200421748
60. Dinkla K, Rohde M, Jansen WT, Kaplan EL, Chhatwal GS, Talay SR. Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen. J Clin Invest (2003) 111(12):1905-12. doi:10.1172/JCI17247
61. Dinkla K, Nitsche-Schmitz DP, Barroso V, Reissmann S, Johansson HM, Frick IM, et al. Identification of a streptococcal octapeptide motif involved in acute rheumatic fever. J Biol Chem (2007) 282(26):18686-93. doi:10.1074/jbc.M701047200
62. Dinkla K, Talay SR, Mörgelin M, Graham RM, Rohde M, Nitsche-Schmitz DP, et al. Crucial role of the CB3-region of collagen IV in PARF-induced acute rheumatic fever. PLoS One (2009) 4(3):e4666. doi:10.1371/journal.pone.0004666
63. Nomura R, Naka S, Nemoto H, Inagaki S, Taniguchi K, Ooshima T, et al. Potential involvement of collagen-binding proteins of Streptococcus mutans in infective endocarditis. Oral Dis (2012) 19(4):387-93. doi:10.1111/odi.12016
64. Linke C, Siemens N, Oehmcke S, Radjainia M, Law RH, Whisstock JC, et al. The extracellular protein factor Epf from Streptococcus pyogenes is a cell surface adhesin that binds to cells through an N-terminal domain containing a carbohydrate-binding module. J Biol Chem (2012) 287(45):38178-89. doi:10.1074/jbc.M112.376434
65. Sela S, Aviv A, Tovi A, Burstein I, Caparon MG, Hanski E. Protein F: an adhesin of Streptococcus pyogenes binds fibronectin via two distinct domains. Mol Microbiol (1993) 10(5):1049-55. doi:10.1111/j.1365-2958.1993.tb00975.x
66. Eichenbaum Z. The streptococcal hemoprotein receptor: a moonlighting protein or a virulence factor? Virulence (2012) 3(7):553-5. doi:10.4161/viru.22440
67. Selinka HC, Wolde A, Sauter M, Kandolf R, Klingel K. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism. Med Microbiol Immunol (2004) 193(2-3):127-31. doi:10.1007/s00430-003-0193-y
68. Orthopoulos G, Triantafilou K, Triantafilou M. Coxsackie B viruses use multiple receptors to infect human cardiac cells. J Med Virol (2004) 74(2):291-9. doi:10.1002/jmv.20184
69. Cifuente JO, Ferrer MF, Jaquenod de Giusti C, Song WC, Romanowski V, Hafenstein SL, et al. Molecular determinants of disease in coxsackievirus B1 murine infection. J Med Virol (2011) 83(9):1571-81. doi:10.1002/jmv.22133
70. Altschul S, Gish W, Miller W, Myers E, Lipman D. Basic local alignment search tool. J Mol Biol (1990) 215(3):403-10. doi:10.1016/S0022-2836(05)80360-2
71. Huang X, Miller W. A time-efficient, linear-space local similarity algorithm. Adv Appl Math (1991) 12:337-57. doi:10.1016/0196-8858(91)90017-D
72. Rudensky AYu, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature (1991) 353(6345):622-7. doi:10.1038/353622a0
73. Root-Bernstein RS. Molecular complementarity III. Molecular complementarity as the basis for peptide hormone evolution. A bioinformatic case study of insulin, glucagon, and gastrin. J Theor Biol (2002) 218:71-84. doi:10.1006/jtbi.2002.3056
74. Root-Bernstein RS, Dobbelstein C. Insulin binds to glucagon forming a complex that is hyper-antigenic and inducing complementary antibodies having an idiotype-antiidiotype relationship. Autoimmunity (2001) 33:153-69. doi:10.3109/08916930109008044
75. Root-Bernstein RS. Antigenic complementarity among AIDS-associated infectious agents and molecular mimicry of lympohocyte proteins as inducers of lymphocytotoxic antibodies and circulating immune complexes. J Clin Virol (2004) 31S:S16-25. doi:10.1016/j.jcv.2004.09.009
76. Root-Bernstein RS. Antigenic complementarity between HIV and other AIDS-associated infections results in idiotype-antiidiotype antibody complexes that cross-react with lymphocyte proteins. Vaccine (2005) 23:2160-3. doi:10.1016/j.vaccine.2005.01.049
77. Root-Bernstein RS, Couturier J. Antigenic complementarity in the origins of autoimmunity: a general theory illustrated with a case study of idiopathic thrombocytopenia purpura. Clin Dev Immunol (2006) 13:49-65. doi:10.1080/17402520600578731
78. Gulizia JM, Cunningham MW, McManus BM. Immunoreactivity of anti-streptococcal monoclonal antibodies to human heart valves. Evidence for multiple cross-reactive epitopes. Am J Pathol (1991) 138(2):285-301
79. Wolff PG, Kühl U, Schultheiss HP. Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J (1989) 117(6):1303-9. doi:10.1016/0002-8703(89)90410-9
80. Wilke A, Schönian U, Herzum M, Hengstenberg C, Hufnagel G, Brilla CG, et al. The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory reaction (article in German). Herz (1995) 20(2):95-108
81. Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest (2000) 106(2):217-24. doi:10.1172/JCI7132
82. Silva-Barbosa SD, Cotta-de-Almeida V, Riederer I, De Meis J, Dardenne M, Bonomo A, et al. Involvement of laminin and its receptor in abrogation of heart graft rejection by autoreactive T cells from Trypanosoma cruzi-infected mice. J Immunol (1997) 159(2):997-1003
83. Silva-Barbosa SD, Savino W. The involvement of laminin in anti-myocardial cell autoimmune response in murine Chagas disease. Dev Immunol (2000) 7(2-4):293-301. doi:10.1155/2000/17424
84. Martins TB, Hoffman JL, Augustine NH, Phansalkar AR, Fischetti VA, Zabriskie JB, et al. Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever. Int Immunol (2008) 20(3):445-52. doi:10.1093/intimm/dxn004
85. De Buyzere ML, De Scheerder IK, Delanghe JR, Robbrecht JH, Clement DL, Wieme RJ. Measurement of autoimmune response against collagen types I, III, and IV by enzyme-linked immunosorbent assay, and its application in infective endocarditis. Clin Chem (1989) 35(2):246-50
86. Gorton D, Blyth S, Gorton JG, Govan B, Ketheesan N. An alternative technique for the induction of autoimmune valvulitis in a rat model of rheumatic heart disease. J Immunol Methods (2010) 355(1-2):80-5. doi:10.1016/j.jim.2010.02.01
87. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol (1990) 57(2):250-62. doi:10.1016/0090-1229(90)90039-S
88. Ciháková D, Sharma RB, Fairweather D, Afanasyeva M, Rose NR. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol Med (2004) 102:175-93
89. Fairweather D, Stafford KA, Sung YK. Update on coxsackievirus B3 myocarditis. Curr Opin Rheumatol (2012) 24(4):401-7. doi:10.1097/BOR.0b013e328353372d
90. Morozova MP, Gavrilova SA, Zemtsova LV, Pogodina LS, Postnikov AB, Chentsov IuS. Dynamic of myocarditis development in rats after injection of cardiac myosine combined with IFA. Ross Fiziol Zh Im I M Sechenova (2012) 98(2):269-82
91. Kato N, Fujii Y, Agata N, Kido N, Ohta M, Naito S, et al. Experimental murine model for autoimmune myocarditis using Klebsiella pneunoniae O-3 lipopolysaccharide as a potent immunological adjuvant. Autoimmunity (1993) 14:231-6. doi:10.3109/08916939309077370
92. Kasahara H, Ito M, Sugiyama T, Kido N, Hayashi H, Saito H, et al. Autoimmune myocarditis induced in mice by cardiac c-protein. J Clin Invest (1994) 94:1026-36. doi:10.1172/JCI117416
93. George J, Adler A, Barshack I, Keren G, Roth A. Suppression of myosin-induced and adoptively transferred myocarditis by prior treatment with complete Freund's adjuvant. Cardiovasc Pathol (2004) 13(4):221-4. doi:10.1016/j.carpath.2004.02.002
94. Burch GE, Giles TD. The role of viruses in the production of heart disease. Am J Cardiol (1972) 29(2):231-40. doi:10.1016/0002-9149(72)90634-0
95. Suresh L, Chandrasekar S, Rao RS, Ravi V, Badrinath S. Coxsackie virus and rheumatic fever. A correlative study. J Assoc Physicians India (1981) 37(9):582-5
96. Vikerfors T, Stjerna A, Olcen P, Malmcrona R, Magnius L. Acute myocarditis. Serologic diagnosis, clinical findings and follow-up. Acta Med Scand (1988) 223(1):45-52. doi:10.1111/j.0954-6820.1988.tb15763.x
97. Zaher SR, Kassem AS, Hughes JJ. Coxsackie virus infections in rheumatic fever. Indian J Pediatr (1993) 60(2):289-98. doi:10.1007/BF02822194
98. Novikov I. O dignostike nervmaticheskikh miokarditov. [Diagnosis of nonrheumatic myocarditis.]. Kardiologiia (1983) 23(5):50-5
99. Kogut EP, Livashova NV, Bondarenk AP, Zherdeva AI, Shuvalova IA. Eksperimental'noe izuchenie koksaki-streptokokkovoi infektsii. [Experimental study of coxsackie-streptococcal infection]. Vopr Virusol (1978) 6:690-5
100. Kuhl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation (2005) 111:887-93. doi:10.1161/01.CIR.0000155616.07901.35
101. Cunningham MW. Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis. Am J Pathol (2001) 159(1):5-12. doi:10.1016/S0002-9440(10)61665-3
102. Daniels MD, Hyland KV, Wang K, Engman DM. Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity. Autoimmunity (2008) 41(6):490-9. doi:10.1080/08916930802167902
103. Nishikubo K, Imanaka-Yoshida K, Tamaki S, Hiroe M, Yoshida T, Adachi Y, et al. Th1-type immune responses by toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis. J Autoimmun (2007) 29(2-3):146-53. doi:10.1016/j.jaut.2007.07.001
104. Okura Y, Takeda K, Honda S, Hanawa H, Watanabe H, Kodama M, et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res (1998) 82(10):1035-42. doi:10.1161/01.RES.82.10.1035
105. Root-Bernstein RS. Antigenic complementarity in the induction of autoimmunity: a general theory and review. Autoimmun Rev (2007) 6(5):272-7. doi:10.1016/j.autrev.2006.09.003
106. Root-Bernstein RS. The role of antigenic complementarity in the induction of autoimmunity. In: Vogel FL, Zimmernan LF, editors. Autoimmunity: Role, Regulation and Disorders. Hauppauge, NY: Nova Press (2008). p. 1-38
107. Pearce JM. Effect of hemolytic toxin of Streptococcus pyogenes on viral myocarditis in rabbit. AMA Arch Pathol (1953) 56:113-22
108. Timpl R, Fujiwara S, Dziadek M, Aumailley M, Weber S, Engel J. Laminin, proteoglycan, nidogen and collagen IV: structural models and molecular interactions. Ciba Found Symp (1984) 108:25-43
109. Charonis AS, Tsilibary EC, Yurchenco PD, Furthmayr H. Binding of laminin to type IV collagen: a morphological study. J Cell Biol (1985) 100:1848-53. doi:10.1083/jcb.100.6.1848
110. Yurchenco PD, Tsilibary EC, Charonis AS, Furthmayr H. Models for the self-assembly of basement membrane. J Histochem Cytochem (1986) 34(1):93-102. doi:10.1177/34.1.3510247
111. Rao CN, Margulies IM, Liotta LA. Binding domain for laminin on type IV collagen. Biochem Biophys Res Commun (1985) 128(1):45-52. doi:10.1016/0006-291X(85)91642-0
112. Charonis AS, Tsilibary EC, Saku T, Furthmayr H. Inhibition of laminin self-assembly and interaction with type IV collagen by antibodies to the terminal domain of the long arm. J Cell Biol (1986) 103(5):1689-97. doi:10.1083/jcb.103.5.1689
113. Laurie GW, Bing JT, Kleinman HK, Hassell JR, Aumailley M, Martin GR, et al. Localization of binding sites for laminin, heparan sulfate proteoglycan and fibronectin on basement membrane (type IV) collagen. J Mol Biol (1986) 189(1):205-16. doi:10.1016/0022-2836(86)90391-8
114. Grant DS, Lebloxnd CP, Kleinman HK, Inoue S, Hassell JR. The incubation of laminin, collagen IV, and heparan sulfate proteoglycan at 35 degrees C yields basement membrane-like structures. J Cell Biol (1989) 108(4):1567-74. doi:10.1083/jcb.108.4.1567
115. Young DM, Himmelfarb S, Harrington WF. On the structural assembly of the peptide chains of heavy meromyosin. J Biol Chem (1965) 240:2428-36
116. Chantler PD, Gratzer WB. The interaction of actin monomers with myosin heads and other muscle proteins. Biochemistry (1976) 15(10):2219-25. doi:10.1021/bi00655a030
117. Biro NA, Szent-Gyorgyi AE. The effect of actin and physico-chemical changes on the myosin ATP-ase system, and on washed muscle. Hung Acta Physiol (1949) 2(1-4):120-33
118. Root Bernstein RS. Rethinking AIDS. New York, NY: Free Press (1993)